Literature DB >> 3817983

D-penicillamine in rheumatoid arthritis.

P Junker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3817983     DOI： 10.1007/bf02748666

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  9 in total

1.  Intra-articular dissociation of the rheumatoid factor.

Authors:  I A JAFFE
Journal:  J Lab Clin Med       Date:  1962-09

Review 2.  D-penicillamine effects on inflammatory and normal connective tissues in rats. Studies on collagen, glycosaminoglycans and nucleic acids with particular reference to antirheumatoid therapy.

Authors:  P Junker
Journal:  Dan Med Bull       Date:  1985-05

3.  Controlled trial of D(-)penicillamine in severe rheumatoid arthritis.

Authors: 
Journal:  Lancet       Date:  1973-02-10       Impact factor: 79.321

4.  Some aspects of the mechanism of action of penicillamine in rheumatoid arthritis.

Authors:  E Munthe; E Jellum; J Aaseth
Journal:  Scand J Rheumatol Suppl       Date:  1979

Review 5.  NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment.

Authors:  J L Decker; D G Malone; B Haraoui; S M Wahl; L Schrieber; J H Klippel; A D Steinberg; R L Wilder
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

Review 6.  Controlled, double-blind, comparative studies of disease modifying anti-rheumatic drugs in the treatment of patients with rheumatoid arthritis. A review.

Authors:  P Halberg
Journal:  Dan Med Bull       Date:  1984-10

7.  Penicillamine in chronic arthritis of childhood.

Authors:  B M Ansell; M A Hall
Journal:  J Rheumatol Suppl       Date:  1981 Jan-Feb

8.  Evaluation of D-penicillamine in juvenile chronic arthritis. A double-blind, multicenter study.

Authors:  A M Prieur; C Piussan; P Manigne; P Bordigoni; C Griscelli
Journal:  Arthritis Rheum       Date:  1985-04

9.  Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial.

Authors:  T K Kvien; H M Høyeraal; B Sandstad
Journal:  J Rheumatol       Date:  1985-06       Impact factor: 4.666
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.